How we got here: AbbVie in oncology
Our oncology story began with a focus on attacking an “unhittable” cancer target.
AbbVie SA/NV - BE-ABBV-210073 (v3.0) - Sep 2022
{%languageSelectorLabel%}
{%activeLanguage%}AbbVie SA/NV - BE-ABBV-210073 (v3.0) - Sep 2022